- Champignon
Brands recently started trading on the Canadian Securities Exchange (CSE)
- The
company also enters into definitive agreement to acquire Artisan Growers
Ltd
- SHRM
specializes in medicinal-mushroom, mushroom-infused products
Champignon Brands Inc. (CSE: SHRM), a wellness company
specializing in the formulation and distribution of a group of
artisanal-mushroom health supplements, recently began trading on the Canadian
Securities Exchange (CSE). In February 2020, SHRM successfully completed an
initial public offering (IPO) through lead agent PI Financial Corp.
Additionally, Champignon Brands will look to secure a listing on the Frankfurt
Stock Exchange and a quotation on the OTC Marketplace in the United States as
soon as is feasible (http://ibn.fm/SzJuo).
“We’ve been assembling a dedicated roster of mycologists and
health and wellness professionals to formulate several distinctive lines of
premium fungi extracts,” Champignon CEO Gareth Birdsall stated in a news
release. “The overall product portfolio is tailored for conscious consumers
looking to support mental health and bolster cognitive performance through medicinal
mushroom-based products.”
As Champignon Brands continues to bolster its product
portfolio, the company also recently announced that it entered into a
definitive agreement to acquire Artisan Growers Ltd., a British-Columbia-based,
craft-mushroom cultivator and supplier. Champignon’s plan is to integrate
Artisan Growers’ craft-mushroom production capacity into its existing
medicinal-mushroom manufacturing, formulation and distribution infrastructure.
Champignon Brands’ focus is to continue to control its
supply chain directly to the end user (http://ibn.fm/LLtPq). Artisan Growers operates a
craft-mushroom cultivation facility that can produce an array of organic craft
mushroom varietals including lion’s mane, chaga, reishi and agaricus blazei.
SHRM’s dedication is to the cultivation, distribution and
proliferation of artisanal-medical mushrooms and associated CPGs (Consumer
Packaged Goods). The company crafts its increasingly evolving portfolio with
the health-conscious consumer in mind, as evidenced by its flagship brand,
Vitality Superteas. A vertically integrated producer of medicinal mushrooms and
related products, Champignon Brands is based in Vancouver, British Columbia.
With a passion for transforming conventional organic teas,
coffees and other consumables with the infusion of a proprietary blend of
artisanal mushrooms, SHRM and its offerings align with the medical research
community’s renewed interest in mushrooms’ health benefits. “Mushrooms contain
protein, vitamins, minerals, and antioxidants. These can have various health
benefits,” reported a recent Medical News Today article titled
‘What is the Nutritional Value of Mushrooms?’ (http://ibn.fm/Q7xCB). The article also states that “the
antioxidant content in mushrooms may help prevent lung, prostate, breast and
other types of cancer, according to the National Cancer Institute.” Harnessing
the power of the humble mushroom, Champignon Brands is helping to shape the
health and wellness product landscape. Champignon Brands has its premium family
of organic, sustainable, vegan and non-GMO (genetically modified organisms)
mushroom and mushroom-infused formulations. The company’s Vitality Superteas
products includes Nourish Force Supertea, a blend of reishi tyobus tea mix;
Mighty Recharge Supertea, created with lion’s mane tropical green ginseng tea
mix; and Brain Enhance Supertea, a blend of cordycep hibiscus and berries tea
mix.
Aside from its impressive product lineup, the company also
has its research and development/product formulation partnership. Champignon
and Drip Coffee Social Ltd. entered into this partnership to facilitate Drip
Coffee Social infusing Champignon’s proprietary, mushroom-extract blend into a
suite of cold-brew coffee products and signature in-house formulations (http://ibn.fm/86VgL). Champignon
sees considerable potential in the CPG space.
The expectation is that the worldwide, functional-food
marketplace that the company is working to enter will reach $34.3 billion by
2024. For 2020, Champignon Brands’ strategy includes the development of cGMP
(Current Good Manufacturing Practice) formulations of bioactive compounds
extracted from plants and fungi (http://ibn.fm/Z9gd7).
Champignon Brands is aggressively pursuing its mission of
researching and distributing premium-medicinal, mushrooms-infused products. Of
note to investors is that the company is targeting high-margin markets and
optimizing its e-commerce and fulfillment infrastructure. Champignon Brands
continues to promote the health and wellness benefits of functional mushrooms
while at the same time offering the potential for significant investor return
on investment.
For more information, visit the company’s website at www.ChampignonBrands.com
NOTE TO INVESTORS: The latest news and updates
relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment